Rapid Micro Biosystems (RPID) Non-Current Assets (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Non-Current Assets of $13.1 million for Q1 2026, down 4.0% sequentially from $13.7 million in Q4 2025, and down 19.17% YoY from $16.3 million in Q1 2025.
Rapid Micro Biosystems (RPID) Non-Current Assets (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Non-Current Assets for 7 years, with the latest figure at $13.1 million in Q1 2026.
- Quarterly Non-Current Assets fell 19.17% year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.7 million (down 19.32% YoY) and the FY2025 annual result came in at $13.7 million, down 20.68% from the prior year.
- Non-Current Assets fell to $13.1 million in Q1 2026 per RPID's latest filing, from $13.7 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $57.3 million in Q3 2022 and troughed at $13.1 million in Q1 2026.
- A 5-year average of $27.9 million and a median of $19.6 million in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets soared 458.59% in 2022, then slumped 55.76% in 2023.
- Over 5 years, Non-Current Assets stood at $52.1 million in 2022, then plunged by 55.76% to $23.0 million in 2023, then declined by 25.11% to $17.3 million in 2024, then decreased by 20.68% to $13.7 million in 2025, then fell by 4.0% to $13.1 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $13.1 million, $13.7 million, and $14.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn | 12.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.19 Mn |
| Mar 31, 2026 | 13.14 Mn |
| Dec 31, 2025 | 13.68 Mn |
| Sep 30, 2025 | 14.46 Mn |
| Jun 30, 2025 | 15.44 Mn |
| Mar 31, 2025 | 16.25 Mn |
| Dec 31, 2024 | 17.25 Mn |
| Sep 30, 2024 | 17.91 Mn |
| Jun 30, 2024 | 18.89 Mn |
| Mar 31, 2024 | 19.57 Mn |
| Dec 31, 2023 | 23.04 Mn |
| Sep 30, 2023 | 35.12 Mn |
| Jun 30, 2023 | 28.20 Mn |
| Mar 31, 2023 | 44.14 Mn |
| Dec 31, 2022 | 52.07 Mn |
| Sep 30, 2022 | 57.34 Mn |
| Jun 30, 2022 | 44.66 Mn |
| Mar 31, 2022 | 43.16 Mn |
| Dec 31, 2021 | 23.05 Mn |
| Sep 30, 2021 | 10.27 Mn |